Development of endothelin receptor antagonists as potential therapeutic agents

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.1, 2003-01, pp. : 33-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E. Noll G. Lüscher T.F.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite

Therapeutic potential of endothelin receptor antagonists in diabetes

By Chakrabarti S. Cukiernik M. Mukherjee S. Chen S.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2873-2888

Informa Healthcare

Access to resources Recommend Favorite

The Development of Cytokine Receptor Antagonists as Potential Therapeutic Agents for the Myeloproliferative Disorders

Current Pharmaceutical Design, Vol. 8, Iss. 5, 2002-03 ,pp. : 357-368

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension

By Tilton Ronald G Brock Tommy A Dixon Richard AF

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1291-1308

Informa Healthcare

Access to resources Recommend Favorite

The renoprotective potential of endothelin receptor antagonists

By Benigni A. Remuzzi G.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 2, 1997-02 ,pp. : 139-149

Informa Healthcare

Access to resources Recommend Favorite